AstraZeneca Aktie

72,65USD 0,06USD 0,08%
AstraZeneca hier für 0 Euro handeln mit finanzen.net zero
WKN: 886715 / ISIN: US0463531089
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,99
T. Rowe Price Associates, Inc. (Investment Management) 1,90
Wellington Management Co. LLP 1,70
PRIMECAP Management Co. 1,46
Capital Research & Management Co. (International Investors) 1,23
Washington Mutual Investors Fund 0,88
Vanguard PRIMECAP Fund 0,85
GQG Partners LLC 0,70
Vanguard Wellington Fund 0,57
Jennison Associates LLC 0,52

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2018 2019 2020 2021 2022
Personal am Ende des Jahres 64 400 70 600 76 100 83 100 83 500
Umsatz pro Mitarbeiter in Mio. EUR 0,34 0,35 0,36 0,46 0,53

Bilanz (in Mio. EUR) - Aktiva

2018 2019 2020 2021 2022
Summe Umlaufvermögen 15 518 15 563 19 544 26 244 22 593
Summe Anlagevermögen 31 581 31 354 36 002 70 049 66 269
Summe Aktiva 60 651 61 377 66 729 105 363 96 483

Bilanz (in Mio. EUR) - Passiva

2018 2019 2020 2021 2022
Gesamtverschuldung/ -verbindlichkeiten 19 113 18 227 20 380 30 781 29 232
Summe Fremdkapital 46 607 46 781 51 091 66 076 59 425
Summe Eigenkapital 14 044 14 596 15 638 39 287 37 058
Summe Passiva 60 651 61 377 66 729 105 363 96 483

Adresse

Cambridge Biomedical Campus, CB2 0AA Cambridge
Telefon +44 (20) 3749-5000
Internet http://www.astrazeneca.com

Management

Adrian Charles Noel Kemp
Secretary
Ahmed M. Hamdy
Member
Alberto Hegewisch
Chief Medical Officer
Andreas Rummelt
Non-Executive Director
Aradhana Sarin
Chief Financial Officer & Executive Director
Cindy L. Hoots
Chief Digital & Information Officer
David Fredrickson
Executive Vice President-Oncology Business Unit
Deborah DiSanzo
Independent Non-Executive Director
Diana Layfield
Non-Executive Director
Euan A. Ashley
Non-Executive Director
Helen MacPhee
Vice President
Iskra Reic
Executive Vice President-Europe & Canada
Jeffrey Pott
CHRO, Chief Compliance Officer & General Counsel
Jonathan Thomas Charles Slade
Group Treasurer
Katarina Ageborg
Chief Compliance Officer & EVP-Sustainability
Kevin G. Lokay
Head-Change Implementation
Marc Pierre Jean Dunoyer
Chief Strategy Officer
Marcus Wallenberg
Independent Non-Executive Director
Margareta Elisabeth Björk
Senior VP & Head-Late-stage Development
Mark White
Global Franchise Head-Fasenra
Menelas NICOLAS Pangalos
EVP-Biopharmaceuticals Research & Development
Michel Demaré
Chairman
Nazneen Rahman
Independent Non-Executive Director
Pam P. Cheng
Executive VP-Operations & Information Technology
Pascal Soriot
Chief Executive Officer & Executive Director
Philip Arthur John Broadley
Senior Independent Non-Executive Director
Regina Fritsche Danielson
SVP, Head-Research & Early Development
Ruud Dobber
Executive VP-Biopharmaceuticals Business
Sarah Miksinski
Senior Director-Global Regulatory Affairs
Sherilyn D. McCoy
Independent Non-Executive Director
Sjoerd Hubben
Vice President-Global Government Affairs & Policy
Susan Mary Galbraith
Executive VP-Oncology Research & Development
Tony Mok
Independent Non-Executive Director
Tyrell J. Rivers
Executive Director-Corporate Development